[The new ESC Guidelines for acute and chronic heart failure 2016].

about

[Acute and chronic heart failure].

P2860

Q52821448-19AFEE9F-EDFD-4B71-894F-8F74661C6FE4

P2860

[The new ESC Guidelines for acute and chronic heart failure 2016].

Item

http://www.wikidata.org/entity/Q52844963

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh-hant

name

[The new ESC Guidelines for acute and chronic heart failure 2016].

@en

[The new ESC Guidelines for acute and chronic heart failure 2016].

@nl

type

Item

label

[The new ESC Guidelines for acute and chronic heart failure 2016].

@en

[The new ESC Guidelines for acute and chronic heart failure 2016].

@nl

prefLabel

[The new ESC Guidelines for acute and chronic heart failure 2016].

@en

[The new ESC Guidelines for acute and chronic heart failure 2016].

@nl

P1476

[The new ESC Guidelines for acute and chronic heart failure 2016].

@en

P2093

B Pieske

http://www.w3.org/2001/XMLSchema#string

C Tschöpe

http://www.w3.org/2001/XMLSchema#string

C U Oeing

http://www.w3.org/2001/XMLSchema#string

P2860

Dose–Response Relationship Between Physical Activity and Risk of Heart FailureCLINICAL PERSPECTIVE

Obesity and natriuretic peptides, BNP and NT-proBNP: mechanisms and diagnostic implications for heart failure

A Randomized Trial of Intensive versus Standard Blood-Pressure Control

Angiotensin-neprilysin inhibition versus enalapril in heart failure

Trends in prevalence and outcome of heart failure with preserved ejection fraction

ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the

The survival of patients with heart failure with preserved or reduced left ventricular ejection fraction: an individual patient data meta-analysis.

Effects of intensive blood-pressure control in type 2 diabetes mellitus.

Beneficial effects of long-term intravenous iron therapy with ferric carboxymaltose in patients with symptomatic heart failure and iron deficiency†.

Treatment of myocardial infarction in a coronary care unit. A two year experience with 250 patients.

P304

655-663

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00059-016-4496-3

http://www.w3.org/2001/XMLSchema#string

P407

Af-Jarmal

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-11-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27858115

http://www.w3.org/2001/XMLSchema#string

P921

heart failure

[The new ESC Guidelines for acute and chronic heart failure 2016].

about

P2860

P2860

[The new ESC Guidelines for acute and chronic heart failure 2016].

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P921